Fritextsökning
Innehållstyper
-
Samuel Lagercrantz: “Companies that do this successfully will take the lead”
The development of new medicines and medical technologies should not focus too narrowly on prolonging life. It is equally important to develop treatments that r...
-
Nobel Prize winner Torsten Wiesel turns 100: “Old men like me should use their experience to help the young”
In 1955, a young Torsten Wiesel jumped on a boat to the US and embarked on a fabulous career as a neuroscientist, crowned with a Nobel Prize for his work. Now 1...
-
It couldn’t be simpler
AI-assisted ZEISS Solution inspects implant coatings automatically.
-
EU Pharmaceutical Legislation Reform
with stricter clinical trial regulations and pharmacovigilance. The reform accelerates access to innovative medicines through streamlined approvals, promotes co...
-
Vinnova is going to establish a new innovation cluster
Vinnova, the Swedish Agency for Innovation Systems, has been commissioned by the government to establish a national innovation cluster for advanced medicines.
-
Automated nitrogen analysis reduces costs per sample
N-Realizer analytical system from C. Gerhardt increases productivity with valve block from Festo
-
Gothenburg, the city of life science – We are ‘Little Boston’
Western Sweden is investing in life science within everything from advanced therapeutic drugs to femtech. At the same time, stakeholders are looking to other in...
-
AI speeds up measurement process
How to inspect coatings ten times faster with a light microscope? The medical technology group Smith+Nephew has been using ZEISS Axio Imager.Z2m since summer 2022.
-
A new special edition and a new event in Copenhagen – This is happening at Life Science Sweden 2024
The new year brings new features for the readers of Life Science Sweden.
-
Tuberkulosbakterier ska svältas ut - ny substans prövas på människa
Det amerikanska forskningsföretaget Calibr planerar att under ett år genomföra en klinisk studie med ett nytt sorts läkemedels mot tuberkulos.
-
Charlotta Gummeson leaves Sahlgrenska Science Park – “It feels sad and exciting at the same time”
With mixed emotions, Charlotta Gummeson will leave her position as CEO of Sahlgrenska Science Park in October. “It feels sad and exciting at the same time. I’ve...
-
AI-Driven Microscopy Image Analysis in Pharma and Biotech
Extract breakthrough discoveries from large, complex data sets.
-
Clean solutions - Handling viscose substances with precision
Laboratories in the chemical, petrochemical, pharmaceutical and food technology industries are increasingly relying on automation for sample preparation. The Mo...
-
Accurate removal of prostate tissue
Medical robots play an important role in diagnostics
-
Faster development of reliable sample handling
Festo USA has collaborated with PerkinElmer to develop a compact sample handling solution for a global leader in manufacturing medical devices. Thanks to the cu...
-
Elicera får mångmiljonbidrag av EU för utveckling av CAR-T-terapi
Cell- och genterapibolaget Elicera Therapeutics tilldelas 2,5 miljoner euro, motsvarande drygt 26 miljoner kronor, i EU-finansiering för fortsatt utveckling av ...
-
Precision and accuracy in liquid handling
How to evaluate and optimize liquid handling performance
-
Save time and money !
Festo Digital engineering tools helps you to calculate the most cost and efficient solution for your application for free
-
Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap
From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered b...
-
Hello Jenni Nordborg!
Life Science Sweden would like to know more about Jenni Nordborg and asks her about her new job, why she became a chemical engineer and who her role model is.
-
Accelerator i Lund kör igen
Health2B är en accelerator för tidiga bolag inom teknik och hälsa, och genomförs i life science-inkubatorn Smiles regi i Lund. Nu startar fjärde omgången.
-
We will now publish more news in English – and offer yet another newsletter
Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.
-
CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”
become disease-free, at least of those treated with Yescarta, which are the ones I know best,” says Gunilla Enblad, Chairman of the national working group for CAR-T treatment.
-
Carl Borrebaeck – professor and serial entrepreneur with a taste for speed
Award-winning cancer researcher, the founder of many listed companies, and constantly in the academic and commercial spotlight for decades. However, Carl Borreb...